Provenance du réseau au premier degré de D. Geoffrey Shulman
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
DUSA Pharmaceuticals, Inc.
 DUSA Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology DUSA Pharmaceuticals, Inc. is an integrated dermatology pharmaceutical company, which develops and markets Levulan Photodynamic Therapy technology platform for the prevention and treatment of dermatological skin conditions. Its products include levulan kerastick, BLU-U and clindareach. The company was founded by D. Geoffrey Shulman on February 21, 1991 and is headquartered in Wilmington, MA.
17
| Subsidiary | Pharmaceuticals: Major | 17 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à D. Geoffrey Shulman via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Sales & Marketing | |
I-Flow Corp.
 I-Flow Corp. Medical SpecialtiesHealth Technology I-Flow Corp. designs, develops and manufactures ambulatory drug delivery systems. Its products include portable infusion pumps, catheters and pain kits. The company was founded in 1985 and is headquartered in Lake Forest, CA. | Medical Specialties | Director/Board Member | |
| ORYX TECHNOLOGY CORP. | Electrical Products | Director/Board Member Director/Board Member | |
| Northlea Partners LLLP | Corporate Officer/Principal | ||
| WEST PHARMACEUTICAL SERVICES, INC. | Medical Specialties | Corporate Officer/Principal Sales & Marketing | |
| CGI INC. | Information Technology Services | Corporate Officer/Principal | |
| CURIS, INC. | Biotechnology | General Counsel | |
| COMBIMATRIX CORP | Biotechnology | Director/Board Member | |
Alison Raffaele Cosmetics, Inc.
 Alison Raffaele Cosmetics, Inc. Specialty StoresRetail Trade Alison Raffaele Cosmetics, Inc. manufactures cosmetics and facial makeup products. Its products include powder, lipstick, lip gloss and blush, tools, and brushes. The firm was founded by Alison Raffaele Tatem in 2000 and is headquartered in Cliffside Park, NJ. | Specialty Stores | Director/Board Member | |
| University of Notre Dame | College/University | Graduate Degree | |
| CITIUS PHARMACEUTICALS, INC. | Medical Specialties | Corporate Officer/Principal | |
| NEUROTROPE, INC. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of Pennsylvania | College/University | Doctorate Degree Masters Business Admin Undergraduate Degree | |
| CALIBER IMAGING & DIAGNOSTICS, INC. | Medical Specialties | Director of Finance/CFO Director/Board Member | |
| Babson College | College/University | Masters Business Admin | |
| Saint Joseph's College (Indiana) | College/University | Undergraduate Degree | |
| University of Birmingham | College/University | Doctorate Degree | |
| FUSS BRANDS CORP. | Pharmaceuticals: Other | Director/Board Member | |
American Academy of Dermatology
 American Academy of Dermatology Miscellaneous Commercial ServicesCommercial Services American Academy of Dermatology is the largest and most influential dermatology group in the United States. The private company is based in the United States and has subsidiaries in various locations. The American company provides resources on membership, education, practice management, publications, and clinical care for dermatologists. The company also offers information for patients and the public on skin, hair, and nail conditions. Elizabeth Usher has been the CEO of the company since 2019. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| MedVest, Inc. | Founder | ||
| Combimatrix Molecular Diagnostics, Inc. | Director/Board Member | ||
| Florida International University Foundation | Investment Trusts/Mutual Funds | Director/Board Member | |
| International University of Health Sciences | College/University | Corporate Officer/Principal | |
| UniMedica, Inc. | Chairman | ||
| CONTRAFECT CORPORATION | Biotechnology | Founder | |
Etubics Corp.
 Etubics Corp. BiotechnologyHealth Technology Etubics Corp. develops commercial prophylactic vaccines and immunotherapy products. It offers proprietary immunization platform technology called the etubics platform that develops therapeutic vaccines for colon and breast cancers and preventative vaccines for H1N1 Influenza and HIV. The company was founded by Frank R. Jones in 2003 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
| Baystar Biosciences | Director/Board Member | ||
| Medezrin Ltd. | Director/Board Member | ||
Medisync Midwest LLC
 Medisync Midwest LLC Miscellaneous Commercial ServicesCommercial Services Medisync Midwest LLC provides consultation services. It offers practice management partnership, clinical research, volume to value planning, diagnostic assessments, and HCC program. The company is headquartered in Cincinnati, OH. | Miscellaneous Commercial Services | Director/Board Member | |
| Higuchi Bioscience Center | Director/Board Member | ||
Cibar, Inc.
 Cibar, Inc. Packaged SoftwareTechnology Services Cibar, Inc. provides software solutions for financial institutions. Its products include global trade services and internet customer connection. The company was founded by Loren E. Shannon in 1969 and is headquartered in Colorado Springs, CO. | Packaged Software | Corporate Officer/Principal | |
Mariinsky Foundation of America
 Mariinsky Foundation of America Miscellaneous Commercial ServicesCommercial Services Mariinsky Foundation of America provides business support services to constituent institutions of the Mariinsky Theatre. The non-profit company is based in New York, NY. | Miscellaneous Commercial Services | Director/Board Member | |
International Opera Alliance
 International Opera Alliance Miscellaneous Commercial ServicesCommercial Services International Opera Alliance is an entertainment company focused on musical and arts activities. The company is headquartered in Fairfax, VA. | Miscellaneous Commercial Services | Director/Board Member | |
| Players Club | Corporate Officer/Principal | ||
OHK Medical Devices, Inc.
 OHK Medical Devices, Inc. Medical SpecialtiesHealth Technology OHK Medical Devices, Inc. develops and manufactures self-contained, sterile, exsanguinating tourniquet products. Its products include hand and wrist, foot and ankle, upper extremity, lower extremity and pediatrics. The company was founded by Noam Gavriely in 1999 and is headquartered in Grandville, MI. | Medical Specialties | Director/Board Member | |
| International Society of Dermatology | Corporate Officer/Principal | ||
| Dalyda Finance LLC | Corporate Officer/Principal | ||
| MEDITE CANCER DIAGNOSTICS INC | Medical Specialties | Director/Board Member | |
Hadean Ventures AS
 Hadean Ventures AS Investment ManagersFinance Hadean Ventures AS (Hadean Ventures) is a venture capital firm that manages alternative investment funds. The firm was founded by Ingrid Helene Teigland Akay in 2014 and is headquartered in Oslo, Norway. | Investment Managers | Private Equity Investor | |
Pattern Pharma, Inc.
 Pattern Pharma, Inc. Pharmaceuticals: MajorHealth Technology Pattern Pharma, Inc. engages in the pharmaceutical industry. Its product named P2PAR addresses the immune failure which underlies infectious diseases and cancers. The company is headquartered in Toronto, Canada. | Pharmaceuticals: Major | Director/Board Member | |
Bryologyx, Inc.
 Bryologyx, Inc. Pharmaceuticals: MajorHealth Technology Bryologyx, Inc. operates as a biopharmaceutical company focused on treating cancer immunotherapies. The company was founded by Thomas M. Loarie, John H. Abeles, Paul A. Wender and Sam Kongsamut and is headquartered in Danville, CA. | Pharmaceuticals: Major | Founder | |
| Society of Concurrent Product Development | Director/Board Member | ||
Oncolyze, Inc.
 Oncolyze, Inc. BiotechnologyHealth Technology Oncolyze, Inc. is a private company developing a novel technology for cancer treatment. The company is based in New York, NY and was founded by Steven J. Evans and John H. Abeles. The company's lead drug candidate targets the cancer cell membrane and selectively kills cancer cells and cancer stem cells while sparing normal cells, potentially providing a highly effective treatment with little to no side effects. The initial therapeutic target is acute myeloid leukemia (AML), a cancer with a low five-year survival rate. Oncolyze's drug has been shown to destroy leukemic cancer stem cells, disrupting current medical treatment. Steven J. Evans has been the CEO since incorporation. | Biotechnology | Founder |
Statistiques
Internationale
| Etats-Unis | 44 |
| Canada | 3 |
| Royaume-Uni | 3 |
| Suisse | 2 |
| Saint Kitts-Nevis | 2 |
Sectorielle
| Health Technology | 20 |
| Consumer Services | 7 |
| Commercial Services | 7 |
| Finance | 4 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 72 |
| Corporate Officer/Principal | 25 |
| Undergraduate Degree | 12 |
| President | 12 |
| Founder | 12 |
Relations les plus connectées
- Bourse
- Insiders
- D. Geoffrey Shulman
- Connexions Sociétés
